438 related articles for article (PubMed ID: 17874073)
1. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.
Carter OL; Hasler F; Pettigrew JD; Wallis GM; Liu GB; Vollenweider FX
Psychopharmacology (Berl); 2007 Dec; 195(3):415-24. PubMed ID: 17874073
[TBL] [Abstract][Full Text] [Related]
2. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.
Carter OL; Pettigrew JD; Hasler F; Wallis GM; Liu GB; Hell D; Vollenweider FX
Neuropsychopharmacology; 2005 Jun; 30(6):1154-62. PubMed ID: 15688092
[TBL] [Abstract][Full Text] [Related]
3. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.
Carter OL; Burr DC; Pettigrew JD; Wallis GM; Hasler F; Vollenweider FX
J Cogn Neurosci; 2005 Oct; 17(10):1497-508. PubMed ID: 16269092
[TBL] [Abstract][Full Text] [Related]
4. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX
Biol Psychiatry; 2012 Dec; 72(11):898-906. PubMed ID: 22578254
[TBL] [Abstract][Full Text] [Related]
5. Effects of psilocybin on time perception and temporal control of behaviour in humans.
Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX
J Psychopharmacol; 2007 Jan; 21(1):50-64. PubMed ID: 16714323
[TBL] [Abstract][Full Text] [Related]
6. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
Kometer M; Schmidt A; Jäncke L; Vollenweider FX
J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
[TBL] [Abstract][Full Text] [Related]
7. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
Bravermanová A; Viktorinová M; Tylš F; Novák T; Androvičová R; Korčák J; Horáček J; Balíková M; Griškova-Bulanova I; Danielová D; Vlček P; Mohr P; Brunovský M; Koudelka V; Páleníček T
Psychopharmacology (Berl); 2018 Feb; 235(2):491-503. PubMed ID: 29302713
[TBL] [Abstract][Full Text] [Related]
8. Acute psilocybin enhances cognitive flexibility in rats.
Torrado Pacheco A; Olson RJ; Garza G; Moghaddam B
Neuropsychopharmacology; 2023 Jun; 48(7):1011-1020. PubMed ID: 36807609
[TBL] [Abstract][Full Text] [Related]
9. Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation.
Frecska E; White KD; Luna LE
Psychopharmacology (Berl); 2004 Apr; 173(1-2):79-87. PubMed ID: 14712339
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
[TBL] [Abstract][Full Text] [Related]
11. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
Hesselgrave N; Troppoli TA; Wulff AB; Cole AB; Thompson SM
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33850049
[TBL] [Abstract][Full Text] [Related]
12. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
[TBL] [Abstract][Full Text] [Related]
13. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.
Quednow BB; Kometer M; Geyer MA; Vollenweider FX
Neuropsychopharmacology; 2012 Feb; 37(3):630-40. PubMed ID: 21956447
[TBL] [Abstract][Full Text] [Related]
14. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
Vollenweider FX; Csomor PA; Knappe B; Geyer MA; Quednow BB
Neuropsychopharmacology; 2007 Sep; 32(9):1876-87. PubMed ID: 17299516
[TBL] [Abstract][Full Text] [Related]
15. Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M
Neuropsychobiology; 2002; 45(4):205-12. PubMed ID: 12097810
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
[TBL] [Abstract][Full Text] [Related]
17. How does binocular rivalry emerge from cortical mechanisms of 3-D vision?
Grossberg S; Yazdanbakhsh A; Cao Y; Swaminathan G
Vision Res; 2008 Sep; 48(21):2232-50. PubMed ID: 18640145
[TBL] [Abstract][Full Text] [Related]
18. Age-dependency in binocular rivalry is reflected by exclusive percepts, not mixed percepts.
Arani E; van Ee R; van Wezel R
Sci Rep; 2019 Dec; 9(1):19271. PubMed ID: 31848422
[TBL] [Abstract][Full Text] [Related]
19. Psilocybin--summary of knowledge and new perspectives.
Tylš F; Páleníček T; Horáček J
Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
[TBL] [Abstract][Full Text] [Related]
20. Inter-ocular transfer of stimulus cueing in dominance selection at the onset of binocular rivalry.
Kamphuisen AP; van Wezel RJ; van Ee R
Vision Res; 2007 Apr; 47(9):1142-4. PubMed ID: 17360017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]